Cumberland Pharmaceuticals (CPIX) Operating Expenses (2010 - 2026)

Cumberland Pharmaceuticals has disclosed Operating Expenses across 17 years of filings, most recently posting $12.3 million for Q1 2026.

• Operating Expenses for Q1 2026 came in at $12.3 million, up 17.65% year-over-year; the trailing twelve-month figure through Mar 2026 was $49.2 million (up 10.82% YoY), and the FY2025 annual result was $47.3 million, up 6.8% from the prior year.
• Operating Expenses came in at $12.3 million for Q1 2026 at Cumberland Pharmaceuticals, down from $15.0 million in the prior quarter.
• In the past five years, Operating Expenses ranged from a high of $15.5 million in Q4 2023 to a low of $10.3 million in Q3 2025.
• The 5-year median for Operating Expenses is $11.6 million (2025), against an average of $11.8 million.
• Across the five-year window, Operating Expenses jumped 36.23% in 2023 and declined 20.95% in 2024, its largest moves.
• Cumberland Pharmaceuticals' Operating Expenses stood at $11.4 million in 2022, then soared by 36.23% to $15.5 million in 2023, then fell by 20.95% to $12.3 million in 2024, then gained by 22.58% to $15.0 million in 2025, then retreated by 18.53% to $12.3 million in 2026.
• The last three Operating Expenses figures came in at $12.3 million (Q1 2026), $15.0 million (Q4 2025), and $10.3 million (Q3 2025), per Business Quant data.